Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan C Fuchs

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Disease Models & Mechanisms|June 16, 2018
Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapyDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Hepatology Communications|May 16, 2018
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitisAnnie J Kruger, Bryan C Fuchs, Ricard Masia, et al.
JAMA|January 3, 2008
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosisKenneth K Tanabe, Antoinette Lemoine, Dianne M Finkelstein, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 19, 2019
The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstructionShen Li, Sarani Ghoshal, Mozhdeh Sojoodi, et al.
Plos One|December 16, 2014
Host genetics predict clinical deterioration in HCV-related cirrhosisLindsay Y King, Kara B Johnson, Hui Zheng, et al.
Quantitative Imaging in Medicine and Surgery|May 19, 2016
T2 relaxation time is related to liver fibrosis severityAlexander R Guimaraes, Luiz Siqueira, Ritika Uppal, et al.
Oncotargets and Therapy|December 24, 2013
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patientsMasaya Suenaga, Suguru Yamada, Tsutomu Fujii, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Disease Models & Mechanisms|June 16, 2018
Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapyDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Hepatology Communications|May 16, 2018
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitisAnnie J Kruger, Bryan C Fuchs, Ricard Masia, et al.
JAMA|January 3, 2008
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosisKenneth K Tanabe, Antoinette Lemoine, Dianne M Finkelstein, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 19, 2019
The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstructionShen Li, Sarani Ghoshal, Mozhdeh Sojoodi, et al.
Plos One|December 16, 2014
Host genetics predict clinical deterioration in HCV-related cirrhosisLindsay Y King, Kara B Johnson, Hui Zheng, et al.
Quantitative Imaging in Medicine and Surgery|May 19, 2016
T2 relaxation time is related to liver fibrosis severityAlexander R Guimaraes, Luiz Siqueira, Ritika Uppal, et al.
Oncotargets and Therapy|December 24, 2013
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patientsMasaya Suenaga, Suguru Yamada, Tsutomu Fujii, et al.
Pageof 10